Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07181434

Impact of Virtual Reality on Patient Pain During Lower Limb Revascularization Via Endovascular Surgery Under Local Anesthesia With Sedation

The prevalence of peripheral arterial disease (PAD) increases with age In addition to medical treatment, endovascular procedures can be performed, depending on the stage of the disease, to prevent complications and/or sequelae (relapse, functional loss of the affected limb, amputation, death), but also to relieve pain. This is a minimally invasive procedure most often performed under local anesthesia (LA), sometimes with the administration of sedatives (morphine and analgesics) to relieve pain and reduce anxiety related to the procedure.

Non-pharmacological methods such as virtual reality (VR) are increasingly being used as an alternative to general anesthesia and excessive opioid use.

The hypothesis is that VR could reduce pain during lower limb revascularization by endovascular surgery.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

The prevalence of peripheral arterial disease (PAD) increases with age. In high-income countries, it is 5% between the ages of 45 and 49, and 18% after the age of 85. In France, nearly 1 million people are affected by this disease.

In addition to medical treatment, endovascular procedures can be performed, depending on the stage of the disease, to prevent complications and/or sequelae (relapse, functional loss of the affected limb, amputation, death), but also to relieve pain. This is a minimally invasive procedure most often performed under local anesthesia (LA), sometimes with the administration of sedatives (morphine and analgesics) to relieve pain and reduce anxiety related to the procedure.

Local anesthesia causes discomfort related to the operating environment (low temperature, harsh lighting, noise, supine position, arms along the body, cold, hard, narrow table), impacting patient cooperation and making the procedure difficult, with the need to take multiple X-rays and reinject potentially nephrotoxic contrast agents. It can lead to the procedure being stopped, with serious consequences (postponement, persistent or even worsening pain, amputation, death).

Non-pharmacological methods such as virtual reality (VR) are increasingly being used as an alternative to general anesthesia and excessive opioid use.

It has proven effective in managing pain and anxiety during various medical, surgical, and endovascular procedures. Its high-quality graphics immerse the patient; hypnotic speech and relaxing elements capture the patient's attention; breathing exercises help manage stress; and relaxing music creates a soothing atmosphere. This support ensures greater mental and physical comfort by reducing pain and anxiety.

The hypothesis is that VR could reduce pain during lower limb revascularization by endovascular surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient suffering from PAD, scheduled to undergo endovascular surgery for lower limb revascularization under local anesthesia combined with sedation.
  • Age ≥ 18 years.
  • Patient who understands and speaks French.
  • Patient covered by social security or covered through a third party.
  • Free subject, without guardianship, curatorship, or subordination.
  • Patient who has given their free and informed consent.

Exclusion criteria

  • Patients with contraindications to VR headsets (mono- or binocular blindness, epilepsy, migraines, psychiatric disorders, pacemakers, hearing aids, defibrillators, recent injuries to the eyes, face, or scalp that prevent comfortable use of the headsets, etc.).
  • Patients with suspected intolerance to VR headsets (sensitivity to motion sickness in cars, history of balance or eye disorders, etc.);
  • Previous bad experience with VR headsets;
  • Patients undergoing local regional anesthesia (LRA);
  • Persons requiring enhanced protection, namely persons deprived of their liberty by judicial or administrative decision, pregnant women, and finally patients in life-threatening situations.

Treatment and study plan

The patient will be equipped with VR headsets

Device

The patient will be equipped with VR headsets showing one of the six scenes from the HealthyMind® program in 3D, accompanied by hypnotic speech during the procedure.

Primary outcomes

  1. The maximum level of pain experienced by the patient during the procedure

    Time frame: At the end of the revascularization procedure

    The maximum level of pain will be assessed at the the end of the procedure using a numerical rating scale ranging from 0 (no pain) to 10 (worst pain imaginable)

Secondary outcomes

  1. The difference in anxiety measures assessed at baseline and just after the intervention

    Time frame: At Baseline and just after the intervention of lower limb revascularization through endovascular surgery

    Anxiety will be measured at baseline and just after the intervention using a numerical rating scale ranging from 0 for "no anxiety" to 10 for "maximum imagined anxiety": a quick, easy-to-use scale that correlates strongly with Spielberger's STAI scale (Benotsch et al., 2000).

  2. Systolic Blood Pressure (SBP) in mmHg

    Time frame: At Baseline before the procedure of lower limb revascularization through endovascular surgery, upon arrival in the operating room, then every 15 minutes until the end of the procedure.

  3. Diastolic Blood Pressure (DBP) in mmHg

    Time frame: At Baseline before the procedure of lower limb revascularization through endovascular surgery, upon arrival in the operating room, then every 15 minutes until the end of the procedure.

  4. Heart Rate (HR) in cycles/min

    Time frame: At Baseline before the procedure of lower limb revascularization through endovascular surgery, upon arrival in the operating room, then every 15 minutes until the end of the procedure.

  5. Respiratory Rate (RR) in Breaths Per Minute (BPM)

    Time frame: At Baseline before the procedure of lower limb revascularization through endovascular surgery, upon arrival in the operating room, then every 15 minutes until the end of the procedure.

  6. Cumulated doses of analgesics consumed during the procedure (in mL/kg)

    Time frame: During the revascularization procedure

    Cumulated doses will be standardized in mL/kg in order to obtain comparable measures accros patients

  7. The dose of X-ray radiation

    Time frame: During the procedure of revascularization of the lower limbs by endovascular surgery

    Total dose of X-ray radiation absorbed by the patient (dose-area product, in mGy.cm²)

  8. The total volume of contrast medium delivered during the procedure

    Time frame: During the procedure of revascularization of the lower limbs by endovascular surgery

  9. The difference between the duration of the procedure as perceived by the patient and the actual duration of the procedure (in minutes)

    Time frame: At the end of the procedure of revascularization of the lower limbs by endovascular surgery

  10. The success rate of the procedure

    Time frame: At the end of the procedure of revascularization of the lower limbs by endovascular surgery

    Proportion of procedures performed successfully (total revascularization of the artery)

  11. Proportion of patients who kept the virtual reality headsets on throughout the procedure

    Time frame: Throughout the procedure of lower limb revascularization through endovascular surgery

    Outcome assessed for the experimental group only (with VR headset)

  12. Satisfaction level of the virtual reality headset

    Time frame: At the end of the procedure of lower limb revascularization through endovascular surgery

    Satisfaction will be measured with a numerical rating scale ranging from 0 (not satisfied at all) to 10 (completely satisfied). Outcome assessed for the experimental group only (with VR headset)

  13. Comfort level experienced by the patient during the procedure

    Time frame: Comfort will be assessed at the end of the revascularization procedure

    Comfort will be measured after the procedure using a numerical rating scale ranging from 0 (very uncomfortable) to 10 (very comfortable).

  14. Cumulated doses of morphine derivatives consumed during the procedure (in mL/kg)

    Time frame: During the revascularization procedure

    Cumulated doses will be standardized in mL/kg in order to obtain comparable measures accross patients

  15. Cumulated doses of anesthetics consumed during the procedure (in mL/kg)

    Time frame: During the revascularization procedure

    Cumulated doses will be standardized in mL/kg in order to obtain comparable measures accross patients

Study contacts

Contact information is provided by the study sponsor or research team.

Amélie PETIT

CONTACT

[email protected]

+33 5 49 44 69 70

Sponsors and collaborators

Lead sponsor

Poitiers University Hospital

Other

Registry information

Official study title

Impact of Virtual Reality on Patient Pain During Lower Limb Revascularization Via Endovascular Surgery Under Local Anesthesia With Sedation - Randomized Study

Acronym: REVDOU

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 18, 2025
Registry last updated
Aug 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.